Want to join the conversation?
$STT 2Q15 Q&A: Schorr from Evercore asked about other operating expenses. Mike replied relative to 2Q15, I’d expect them to be lower in 3Q15 & 4Q15 subject to the caveat that if 1) we are effective in executing the initiatives that we’ve on the table, 2) we are successful in hiring additional full time staff to replace outside consulting expenses.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?